Enroll in Mirum Access
Plus (MAP)
Receive support for every step of your LIVMARLI treatment.
Store LIVMARLI at room temperature between
68 °F and 77 °F
(20 °F and 25 °F)
Properly dispose of any unused LIVMARLI
45 Days
after first opening of bottle
Always store LIVMARLI with the
cap on
the bottle
Keep LIVMARLI and all medicines out of reach of children.
When starting a medication, especially for a rare liver disease such as Alagille syndrome, it’s important to talk to your or your child’s doctor so they can help you better understand what to expect.
Don’t stop or change the dose on your own without talking to your doctor first.
Receive support for every step of your LIVMARLI treatment.
Learn about the results of LIVMARLI in the battle against the itch in Alagille syndrome.
LIVMARLI is a prescription medicine used to treat cholestatic pruritus (itch) in patients with Alagille syndrome 1 year of age and older. It is not known if LIVMARLI is safe and effective in children under 1 year of age or in adults 65 years and older.
What are the possible side effects
of LIVMARLI?
LIVMARLI can cause serious side effects, including:
Changes in liver tests. Changes in certain liver tests are common in patients with Alagille syndrome but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:
Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea, stomach pain, and vomiting during treatment. Tell your health care provider right away if you have any of these symptoms more often or more severely than normal for you.
A condition called Fat Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamins A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment.
Other common side effects reported during treatment were bone fractures and gastrointestinal bleeding.
Tell your health care provider about all medicines that you take. LIVMARLI may affect the way some other medicines work, and some other medicines may affect the way LIVMARLI works. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take it at least 4 hours before or 4 hours after you take LIVMARLI.
LIVMARLI is taken by mouth, 1 time each day, 30 minutes before the first meal of the day. Be sure to use the provided oral dosing dispenser to accurately measure the dose of medicine.
These are not all of the possible side effects of LIVMARLI. Call your health care provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see Patient Information.